ahlam1399
03-24-2016, 05:20 PM
BRIEF-Biomarin- gets European orphan drug designation for Gene Therapy drug for Hemophilia A
* Receives European orphan drug designation for bmn 270,first investigational aav-factor viii gene therapy for patientswith hemophilia aSource text for Eikon: Further company coverage:http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YMS2gzz8mjs:FmhcDkljK7A:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=YMS2gzz8mjs:FmhcDkljK7A:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YMS2gzz8mjs:FmhcDkljK7A:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=YMS2gzz8mjs:FmhcDkljK7A:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YMS2gzz8mjs:FmhcDkljK7A:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/YMS2gzz8mjs
* Receives European orphan drug designation for bmn 270,first investigational aav-factor viii gene therapy for patientswith hemophilia aSource text for Eikon: Further company coverage:http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YMS2gzz8mjs:FmhcDkljK7A:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=YMS2gzz8mjs:FmhcDkljK7A:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YMS2gzz8mjs:FmhcDkljK7A:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=YMS2gzz8mjs:FmhcDkljK7A:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=YMS2gzz8mjs:FmhcDkljK7A:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/YMS2gzz8mjs